HIGHLIGHTS
- who: David C. Knox et al. from the Prophylaxis for HIV Prevention in Canada University of Toronto, Toronto, ON, Canada have published the paper: Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada, in the Journal: Canadian Journal of Infectious Diseases and Medical Microbiology of 30/08/2022
- what: There are robust data on the efficacy of FTC/TDF PrEP for the following populations: MSM, transgender women, heterosexuals whose partners are living with HIV, and PWID.
- future: The clinical significance of the observed weight gain has not been established . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.